B3GALT6 antibody (C-Term)
Quick Overview for B3GALT6 antibody (C-Term) (ABIN635815)
Target
See all B3GALT6 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- B3 GALT6 antibody was raised against the C terminal of B3 ALT6
-
Purification
- Affinity purified
-
Immunogen
- B3 GALT6 antibody was raised using the C terminal of B3 ALT6 corresponding to a region with amino acids VQREHDPRFDTEYRSRGCSNQYLVTHKQSLEDMLEKHATLAREGRLCKRE
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
B3GALT6 Blocking Peptide, (ABIN5612257), is also available for use as a blocking control in assays to test for specificity of this B3GALT6 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of B0 ALT6 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- B3GALT6 (UDP-Gal:betaGal beta 1,3-Galactosyltransferase Polypeptide 6 (B3GALT6))
-
Alternative Name
- B3GALT6
-
Background
- B3GALT6 (Beta-1,3-galactosyltransferase) transfers galactose from UDP-galactose to substrates with a terminal beta-linked galactose residue. It has a preference for galactose-beta-1,4-xylose that is found in the linker region of glycosaminoglycans, such as heparan sulfate and chondroitin sulfate. It has no activity towards substrates with terminal glucosamine or galactosamine residues.
-
Molecular Weight
- 37 kDa (MW of target protein)
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-